Liver Superior Response Rates, Survival Seen With Personalized Versus Standard Dosimetry Approach in HCC By Brandon May
General Gastroenterology Pandemic-Related Delays in Cancer Screenings and Treatment Threaten Progress in Cancer Mortality Rates By Tara Haelle
Pancreatic Disorders Pancreatic Cancer Action Network Launches Adaptive Clinical Trial Platform Aimed at Expediting Drug Development By Rachel Narozniak, MA
General Gastroenterology Evolving Incidence Trends in AYA Cancers By Andrea S. Blevins Primeau, PhD, MBA
General Gastroenterology Targeted Therapies, Immunotherapies, and Immunomodulators: A Quick Guide to Cancer Therapy By Katarina Zimmer, MSci, MS
Pancreatic Disorders Neoadjuvant Urelumab-Containing Combination Has Preliminary Activity in Pancreatic Cancer By Andrea S. Blevins Primeau, PhD, MBA
Pancreatic Disorders New-Onset Diabetes Identified as Potential Biomarker for Pancreatic Cyst Progression By Brandon May
Pancreatic Disorders HIF1A Activity May Suppress Tumors in Pancreatic Cancer Cells By Virginia A. Schad, PharmD, RPh
Pancreatic Disorders Utility of Intracystic Glucose for Diagnosis of Mucinous, Non-Mucinous Pancreatic Cysts Examined By Emily Pond
Pancreatic Disorders Zenocutuzumab Gets Orphan Drug Designation for Pancreatic Cancer By Brian Park, PharmD
Pancreatic Disorders Diagnosing and Managing Patients With Primary Pancreatic Lymphoma By Roxanne Nelson, RN, BSN
Pancreatic Disorders Best Practices to Screen for Pancreatic Cancer in High-Risk Individuals By Jessica Nye, PhD
Pancreatic Disorders Addition of Pegilodecakin to FOLFOX Did Not Improve OS in Metastatic Pancreatic Cancer By Susan Moench, PhD, PA-C
Pancreatic Disorders A Model for Predicting the Risk of Healthy Organ Exposure in Patients With Locally Advanced Pancreatic Cancer Treated With SBRT By Susan Moench, PhD, PA-C